Targeting CDK5 promotes survival of Drosophila with brain tumors16, enhances antitumor immunity by reducing tumor PD-L1 expression15, and impairs mitochondrial dynamics in brain tumor-initiating cells18. This evidence concerns the gene CDK5 and brain neoplasm.